Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wearable device aims to spot trouble before It's too late for ICU survivors

NCT ID NCT06815718

Knowledge-focused Sponsor: Erasmus Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a wearable device called viQtor on 180 adults who had just left the ICU. The device continuously tracks heart rate, breathing rate, oxygen levels, and activity. The goal was to create a new early warning score that could alert nurses sooner if a patient's condition worsens, compared to standard checks. The study is now complete and focused on developing and validating this scoring system.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
viQtor continuous monitoring device
What this could lead to
If successful, this could lead to a better early warning system for patients leaving the ICU, potentially reducing emergency interventions and readmissions.
What could go wrong
This is a small, completed observational study focused on developing a scoring system, not testing a treatment. The device may not improve outcomes in real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

180 people

The number who actually took part.

Started

Feb 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study will be conducted at Erasmus MC and will include 180 hospitalized adults (aged 18 years and older) who have received ICU care and are subsequently transferred to a general ward within the Erasmus MC.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults ≥18 years of age * Written informed consent is obtained from the patient * Expected hospitalization time after ICU discharge of 2 days or longer Exclusion Criteria: * The patient is unable to communicate in Dutch or English * The patient has an allergy to metal or plastics (as the viQtor device contains these materials) * The patient has significant deformities, swelling, irritation, degenerative changes, local infection, ulceration, skin lesions, or edema of the upper arms. * The patient has tattoos on both upper arms where the device's PPG sensor would be placed * The patient experiences tremors/and or convulsions affecting the upper arm

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Early warning score are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Early warning score Monitoring Rapid response system Readmission Telemedicine-based education

Contacts and locations

Locations

  • Erasmus MC

    Rotterdam, South Holland, 3015GD, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.